Pfizer Sees Steep 2023 Fall in COVID Sales, Aims to Bolster Pipeline Pfizer Sees Steep 2023 Fall in COVID Sales, Aims to Bolster Pipeline
Pfizer on Tuesday forecast a bigger-than-expected drop in sales of its COVID-19 vaccine and treatment for 2023, intensifying investor concerns over demand for the products as governments cut orders and work through inventories.Reuters Health Information (Source: Medscape Medical News Headlines)
Source: Medscape Medical News Headlines - February 1, 2023 Category: Consumer Health News Tags: Infectious Diseases News Source Type: news

James Gunn Addresses Backlash Over ‘Shazam’ Star Zachary Levi’s Anti-Pfizer Tweet
As the DC Universe enters Chapter One of its era under bosses James Gunn and Peter Safran, Zachary Levi created quite the “fury” on social media after tweeting a message that was anti-Pfizer. Levi quote-tweeted a message by Lyndon Wood that read, “Do you agree or not, that Pfizer is a real danger…#dcuniverse #chapterone #jamesgunn #petersafran #zacharylevi #lyndonwood #shazam #departmentofjustice #zachlevi (Source: Reuters: Health)
Source: Reuters: Health - February 1, 2023 Category: Consumer Health News Source Type: news

Pfizer could offload Durham facility as part of R & D strategy shift
Pfizer is rethinking its strategy for early-stage drug development for rare diseases, meaning a large facility in Durham could soon hit the market. (Source: bizjournals.com Health Care:Pharmaceuticals headlines)
Source: bizjournals.com Health Care:Pharmaceuticals headlines - January 31, 2023 Category: Pharmaceuticals Authors: Zac Ezzone Source Type: news

With pandemic waning, Pfizer sees decline for its Covid products
Pfizer finished 2022 in strong form, besting fourth-quarter analyst predictions and setting both revenue and earnings records for the year. (Source: bizjournals.com Health Care:Pharmaceuticals headlines)
Source: bizjournals.com Health Care:Pharmaceuticals headlines - January 31, 2023 Category: Pharmaceuticals Authors: Ben Miller Source Type: news

Pfizer reports record revenue, expects Covid-19 vaccines to be commercialized later this year
Pharmaceutical giant Pfizer expects billions less in revenue this year as the U.S. government stops buying its Covid-19 vaccine and treatments and fewer people seek shots to combat the disease. The anticipated revenue decline underscores how federal subsidies have bolstered the drug industry…#pfizer #comirnaty #albertbourla #bourla #moderna #mrna #fda #vaccines #rsv (Source: Reuters: Health)
Source: Reuters: Health - January 31, 2023 Category: Consumer Health News Source Type: news

The end of the Covid health emergency won't slow FDA clearance of shots and treatments
Vials and a medical syringe seen displayed in front of the Food and Drug Administration (FDA) of the United States logo. FDA finds the COVID-19 vaccine. The Food and Drug Administration on Tuesday said its emergency authorizations of Covid vaccines, tests and treatments will not be impacted by the…#fda #health #alexazar #pfizer #johnsonjohnson #novavax #molnupiravir (Source: Reuters: Health)
Source: Reuters: Health - January 31, 2023 Category: Consumer Health News Source Type: news

The Covid sales boom is over for Pfizer
Pfizer generated nearly $57 billion in combined sales last year from its Comirnaty Covid-19 vaccine and Paxlovid antiviral pill. That works out to almost 60% of the company’s total revenue for 2022. But the boom appears to be over. Pfizer (PFE) told Wall Street Tuesday that it expects…#comirnaty #paxlovid #pfe #bntx #pfizer #refinitiv #albertbourla #arenapharmaceuticals #rsv (Source: Reuters: Health)
Source: Reuters: Health - January 31, 2023 Category: Consumer Health News Source Type: news

Pfizer ’s COVID revenues have dropped off along with attention to the pandemic
Pfizer PFE updated its yearly sales guidance for Comirnaty, the COVID-19 vaccine it developed with BioNTech BNTX, saying it now expects $13.5 billion in revenue this year. The shot brought in $37.8 billion in 2022. The drugmaker also lowered revenue expectations for its COVID antiviral, Paxlovid,…#comirnaty #bntx (Source: Reuters: Health)
Source: Reuters: Health - January 31, 2023 Category: Consumer Health News Source Type: news

The Covid pandemic drives Pfizer's 2022 revenue to a record $100 billion
Empty vials of Pfizer-BioNTech coronavirus disease (COVID-19) children's vaccines are pictured at Skippack Pharmacy in Schwenksville, Pennsylvania, U.S., May 19, 2022. The ongoing Covid-19 pandemic propelled pharmaceutical company Pfizer's earnings to a record $100 billion last year, almost $57…#skippackpharmacy #schwenksville #pennsylvania #pfizer #eps #albertbourla #rsv (Source: Reuters: Health)
Source: Reuters: Health - January 31, 2023 Category: Consumer Health News Source Type: news

Pfizer Expects Covid Vaccine And Pill Revenues Will Fall 60% In 2023
Shares of the pharmaceutical giant fell Tuesday as investors respond to lower projected sales for Pfizer ’s core products combatting Covid-19. (Source: Forbes.com Healthcare News)
Source: Forbes.com Healthcare News - January 31, 2023 Category: Pharmaceuticals Authors: Derek Saul, Forbes Staff Tags: Business /business Money /money Markets /markets Innovation /innovation Healthcare /healthcare Breaking breaking-news Coronavirus Education Source Type: news

Video of Pfizer Employee Explaining COVID Vaccine Research Debunked
(MedPage Today) -- Project Veritas, a conservative activist group known for spreading misinformation, recently published a concealed-camera video allegedly showing a Pfizer employee describing the company's COVID-19 vaccine research efforts. As... (Source: MedPage Today Infectious Disease)
Source: MedPage Today Infectious Disease - January 31, 2023 Category: Infectious Diseases Source Type: news

Pfizer could offload Durham facility as part of R & D strategy shift
Pfizer is rethinking its strategy for early-stage drug development for rare diseases, meaning a large facility in Durham could soon hit the market. (Source: bizjournals.com Health Care:Pharmaceuticals headlines)
Source: bizjournals.com Health Care:Pharmaceuticals headlines - January 31, 2023 Category: Pharmaceuticals Authors: Zac Ezzone Source Type: news

Biden Administration Will End Covid-19 Emergency Declarations On May 11
The Biden administration will allow the ongoing Covid-19 emergency declarations to end on May 11, the White House announced on Monday, as part of a wider pivot to treat the coronavirus as an endemic seasonal threat coming less than a week after the FDA proposed an overhaul of its vaccination…#fda #whitehouses #pandemicisoveract #pfizer #cdc (Source: Reuters: Health)
Source: Reuters: Health - January 31, 2023 Category: Consumer Health News Source Type: news

President Joe Biden Announces COVID-19 National Emergencies Will End on May 11
WASHINGTON — President Joe Biden informed Congress on Monday that he will end the twin national emergencies for addressing COVID-19 on May 11, as most of the world has returned closer to normalcy nearly three years after they were first declared. The move to end the national emergency and public health emergency declarations would formally restructure the federal coronavirus response to treat the virus as an endemic threat to public health that can be managed through agencies’ normal authorities. Read More: COVID-19 Is No Longer a Public Health Emergency It comes as lawmakers have already ended elements of the ...
Source: TIME: Health - January 31, 2023 Category: Consumer Health News Authors: Zeke Miller and Amanda Seitz / AP Tags: Uncategorized COVID-19 overnight wire Source Type: news

Exxon Mobil, Pfizer, McDonald's earnings: 3 things to watch By
Investing.com -- Stocks were falling on Monday as investors prepared for the Federal Reserve's next on interest rates on Wednesday plus a slew of earnings reports from tech giants. The Fed is another one-quarter of a percentage point, but Chair Jerome Powell will answer reporters' questions in the…#federalreserve #chairjeromepowell #metaplatforms #apple #amazoncom #exxonmobilcorp #pfizerinc #mcdonaldscorporation (Source: Reuters: Health)
Source: Reuters: Health - January 31, 2023 Category: Consumer Health News Source Type: news